Find Jobs
Find Jobs Near You – Available Work in Your Location
Skip to job details
1C
1095 CSL Behring AG (CH)
Director, Search & Evaluation Early TA Lead (Haem)
Career Insights for Corporate Development Manager
See where this job fits in the broader career landscape. Knowing your career path helps you see what's possible from here.
Scorecard
Based on Massachusetts data
Review key factors to help you decide if this role fits your goals. How is this calculated?
What they do
A Corporate Development Manager helps develop, manage and analyze corporate development through mergers and acquisitions or strategic alliances. Leads research, cost/benefit analyses of mergers, and communicates results to stakeholders. Includes developing and maintaining professional relationships, marketing the proposed changes and assisting in transitions.
$164,077 / year median in Massachusetts
+3% projected growth
Job Description
CSL is expanding its external innovation capability, and we're looking for a Director of Search & Evaluation to help shape the future of our Haematology portfolio. We are seeking a Director of Search & Evaluation to lead strategic sourcing and evaluation of external innovation opportunities in the Haematology therapeutic area. Embedded within the Therapeutic Area Leadership Team (TALT), this position will identify and advance high-potential assets from preclinical through Phase 1 clinical stages, shape early partnering strategies, and drive transactions in collaboration with Business Development. To be hybrid-based onsite (3 days a week) at one of our R D hub sites: Zurich (CH), Maidenhead (UK), Waltham (US), King of Prussia (US). This position cannot be held remotely. Main Responsibilities & Accountabilities Serve as the senior Early S&E leader within the TALT, influencing therapeutic strategy and ensuring external innovation priorities are integrated into portfolio planning. Lead proactive sourcing and scouting efforts for preclinical and Phase 1 assets, building a robust pipeline of opportunities aligned with TA strategy. Co-lead internal meetings (with Late Search Lead) focused on evaluating and prioritizing New Product Opportunities (NPOs) within Haematology. NPO meetings are strategic checkpoints where cross-functional teams review potential assets identified by Search and decide whether to advance them for further due diligence and deal negotiations. Develop and execute early partnering strategies, including onboarding approaches and competitive positioning for priority assets. Drive cross-functional due diligence for each opportunity, coordinating scientific, clinical, regulatory, and commercial assessments to inform governance decisions.